ITMN option expensive

I

Informed

Suggest short May at money straddles to take advantage of the high premiums. I predict FDA will approve, but the share price won't move above 50.

Target price

Approval 50 (50%)
Approval with tough restriction or post approval study 45 (25%)
Request more data but no more new trial 38 or other delay (20%)
More data new trial 22 (5%)
 
It always amazes me people think that readers should take positions based on recommendations from anonymous strangers on the internets.

:confused:
 
Quote from Informed:
----Suggest short May at the money straddles to take advantage of the high premiums. I predict FDA will approve, but the share price won't move above 50.
More...
Just like DNDN......easy money to be made with those juicy premiums. :D :eek: :(
 
I've also collected some short OTM put premiums on ITMN. We shall see the results very soon. (I was in DNDN too--hopefully it will be a replay of that: approval).
 
Quote from donnap:

Halted
More...
It's about time. I'm tired of looking at its super charged high IV quotes, trying to find a good hedged position that wins no matter what the stock does

:D
 
Quote from spindr0:

It's about time. I'm tired of looking at its super charged high IV quotes, trying to find a good hedged position that wins no matter what the stock does
More...

:D My sentiments exactly. No fills on my orders.
 
You must log in or register to reply here.
Back
Top